scieee Science in your language
[en] (orig)

Genetic and cellular sensitivity of Caenorhabditis elegans to the chemotherapeutic agent cisplatin

Abstract

Cisplatin and derivatives are commonly used as chemotherapeutic agents. Although the cytotoxic action of cisplatin on cancer cells is very efficient, clinical oncologists need to deal with two major difficulties, namely the onset of resistance to the drug and the cytotoxic effect in patients. Here, we used Caenorhabditis elegans to investigate factors influencing the response to cisplatin in multicellular organisms. In this hermaphroditic model organism, we observed that sperm failure is a major cause of cisplatin-induced infertility. RNA sequencing data indicate that cisplatin triggers a systemic stress response, in which DAF-16/FOXO and SKN-1/NRF2, two conserved transcription factors, are key regulators. We determined that inhibition of the DNA damage-induced apoptotic pathway does not confer cisplatin protection to the animal. However, mutants for the pro-apoptotic BH3-only gene ced-13 are sensitive to cisplatin, suggesting a protective role of the intrinsic apoptotic pathway. Finally, we demonstrated that our system can also be used to identify mutations providing resistance to cisplatin and therefore potential biomarkers of innate cisplatin-refractory patients. We show that mutants for the redox regulator trxr-1, ortholog of the mammalian thioredoxin reductase 1 TRXR1, display cisplatin resistance. By CRISPR/Cas9, we determined that such resistance relies on the presence of the single selenocysteine residue in TRXR-1.

Read accessible full text

Genetic and cellular sensitivity of Caenorhabditis elegans to the chemotherapeutic agent cisplatin

Author: García-Rodríguez, Francisco Javier; Martínez-Fernández, Carmen; Brena, David; Kukhtar, Dmytro; Serrat, Xènia; Nadal, Ernest; Boxem, Mike; Honnen, Sebastian; Miranda Vizuete, Antonio; Villanueva, Alberto; Cerón, Julián
Publisher: Company of Biologists Limited
Year: 2018
DOI: 10.1242/dmm.033506
Source: https://idus.us.es/bitstreams/eb63e5fb-a523-483b-b76c-29878672050e/download
RESEARCH ARTICLE
Gene ic and cellula sensi i i y o Caeno habdi is elegans o he
chemo he apeu ic agen cispla in
F ancisco Ja ie Ga cı
a-Rod ı
guez
1,2
, Ca men Ma ı
nez-Fe nandez
1
, Da id B ena
1
, Dmy o Kukh a
1
,
Xenia Se a
1
, E nes Nadal
3
, Mike Boxem
4
, Sebas ian Honnen
5
, An onio Mi anda-Vizue e
6
,
Albe o Villanue a
2,
*and Julian Ce on
1,
*
ABSTRACT
Cispla in and de i a i es a e commonly used as chemo he apeu ic
agen s. Al hough he cy o oxic ac ion o cispla in on cance cells is
e y e icien , clinical oncologis s need o deal wi h wo majo
di icul ies, namely he onse o esis ance o he d ug and he
cy o oxic e ec in pa ien s. He e, we used Caeno habdi is elegans o
in es iga e ac o s in luencing he esponse o cispla in in mul icellula
o ganisms. In his he maph odi ic model o ganism, we obse ed ha
spe m ailu e is a majo cause o cispla in-induced in e ili y. RNA
sequencing da a indica e ha cispla in igge s a sys emic s ess
esponse, in which DAF-16/FOXO and SKN-1/NRF2, wo conse ed
ansc ip ion ac o s, a e key egula o s. We de e mined ha inhibi ion
o he DNA damage-induced apop o ic pa hway does no con e
cispla in p o ec ion o he animal. Howe e , mu an s o he p o-
apop o ic BH3-only gene ced-13 a e sensi i e o cispla in, sugges ing
a p o ec i e ole o he in insic apop o ic pa hway. Finally, we
demons a ed ha ou sys em can also be used o iden i y mu a ions
p o iding esis ance o cispla in and he e o e po en ial bioma ke s o
inna e cispla in- e ac o y pa ien s. We show ha mu an s o he
edox egula o x -1, o holog o he mammalian hio edoxin
educ ase 1 TRXR1, display cispla in esis ance. By CRISPR/Cas9,
we de e mined ha such esis ance elies on he p esence o he
single selenocys eine esidue in TRXR-1.
This a icle has an associa ed Fi s Pe son in e iew wi h he i s
au ho o he pape .
KEY WORDS: Caeno habdi is elegans, RNA-seq, Cispla in
INTRODUCTION
The US Food and D ug Adminis a ion app o ed he use o cispla in
[CDDP, cis-diammine-dichlo opla inum(II)] as a chemo he apeu ic
agen in 1978. Since hen, cispla in and o he pla inum-based
de i a i es ha e been used success ully in cance ea men . To
illus a e hei impac in he clinic, i has been es ima ed ha
app oxima ely hal o all pa ien s unde going chemo he apeu ic
ea men ecei e a pla inum d ug (Galanski, 2006). Cispla in exe s
ac i i y agains a wide spec um o solid neoplasms, including
es icula , bladde , o a ian, head and neck, gas ic and lung cance s
(Dasa i and Be na d Tchounwou, 2014). S ikingly, es icula
cance was p e iously a al, bu ea men wi h cispla in p o ided a
cu e o 80% o he pa ien s (Gonzalez-Exposi o e al., 2016).
Despi e i s e ec i eness, he e a e pa ien s in insically esis an o
cispla in-based he apies, and an impo an ac ion o umo s
e en ually de elop chemo esis ance (Amable, 2016).
Cispla in is composed o a double-cha ged pla inum ion
su ounded by ou ligands, wo amines and wo chlo ides. Inside
cells, he low chlo ide concen a ion acili a es cispla in aqua ion,
eplacing chlo ide g oups by wa e molecules. This p ocess p oduces
a hyd olyzed (o aqua ed) o m o cispla in ha is a po en elec ophile
(a ac ed o elec ons) ha can eac wi h any nucleophile, including
nucleic acids and he sul hyd yl g oups o p o eins (Kelland, 2007).
Cispla in ac i i y has an impac in he nucleus and in he
cy oplasm. In he nucleus, cispla in p oduces DNA in a- and
in e s and c osslinks ha lead o apop osis (Kelland, 2007). In he
cy oplasm, owing o i s elec ophilic ac i i y, cispla in beha es as an
oxidan (loss o elec ons esul s in oxida ion), binding o p o eins,
including mi ochond ial p o eins, and especially o hiol g oups
(-SH). Thus, cispla in p oduces a eac i e oxygen species
homeos asis imbalance ha leads o mo e oxidizing condi ions,
which iola e no mal cellula unc ion and, ul ima ely, can also
p omo e apop osis (Wang and Lippa d, 2005). As a esul o i s
b oad and unspeci ic mode o ac ion, cispla in also a ec s no mal
cells. Neph o oxici y, neu o oxici y and o o oxici y a e some o he
dose-limi ing side e ec s epo ed upon cispla in he apy (Kelland,
2007). Ne e heless, he majo obs acle o he clinical e icacy o
cispla in as an an icance d ug is he chemo esis ance de eloped by
umo s a he han i s oxici y in no mal cells.
The acquisi ion o cispla in esis ance is mul i ac o ial. The
mechanisms by which umo cells become esis an o he ac ion o
cispla in ha e been classi ied in o h ee ypes (Galluzzi e al., 2014):
(1) p e- a ge mechanisms, i.e. educing in acellula accumula ion
o cispla in o inc easing seques a ion o cispla in by nucleophilic
sca enge s as glu a hione (GSH), me allo hioneins and o he
cys eine- ich p o eins; (2) on- a ge mechanisms, i.e. acqui ing he
abili y o epai adduc s o becoming ole an o un epai ed DNA
lesions; and (3) pos - a ge mechanisms, i.e. hampe ing he
execu ion o apop osis in esponse o DNA damage (Siddik, 2003).
Recei ed 8 Janua y 2018; Accep ed 10 Ap il 2018
1
Modeling human diseases in C. elegans. Genes, Diseases and The apies
P og am, Bell i ge Biomedical Resea ch Ins i u e - IDIBELL, L’Hospi ale de
Llob ega , 08908 Ba celona, Spain.
2
P og am Agains Cance The apeu ic
Resis ance (P oCURE), Ca alan Ins i u e o Oncology (ICO), Bell i ge Ins i u e o
Biomedical Resea ch (IDIBELL), L’Hospi ale del Llob ega , 08908 Ba celona,
Spain.
3
Tho acic Oncology Uni , Depa men o Medical Oncology, Ca alan Ins i u e
o Oncology (ICO), L’Hospi ale de Llob ega , 08908 Ba celona, Spain.
4
Di ision o
De elopmen al Biology, Depa men o Biology, Facul y o Science, U ech
Uni e si y, 3584 CH U ech , The Ne he lands.
5
Hein ich Heine Uni e si y
Du
sseldo , Medical Facul y, Ins i u e o Toxicology, D-40225 Du
sseldo , Ge many.
6
Ins i u o de Biomedicina de Se illa, Hospi al Uni e si a io Vi gen del Rocı

o/CSIC/
Uni e sidad de Se illa, E-41013 Se illa, Spain.
*Au ho s o co espondence ([email p o ec ed]; [email p o ec ed])
F.J.G., 0000-0001-9933-1990; C.M., 0000-0003-1544-4387; D.B., 0000-0003-
3318-5120; A.V., 0000-0002-4164-6671; J.C., 0000-0003-4739-2243
This is an Open Access a icle dis ibu ed unde he e ms o he C ea i e Commons A ibu ion
License (h p://c ea i ecommons.o g/licenses/by/3.0), which pe mi s un es ic ed use,
dis ibu ion and ep oduc ion in any medium p o ided ha he o iginal wo k is p ope ly a ibu ed.
1
© 2018. Published by The Company o Biologis s L d
|
Disease Models & Mechanisms (2018) 11, dmm033506. doi:10.1242/dmm.033506
Disease Models & Mechanisms
Caeno habdi is elegans is a well-es ablished o ganism o he
s udy o signaling pa hways in esponse o d ug exposu e (Kale a
and Henga ne , 2006). P e ious s udies, pe o med in dis inc
biological con ex s (Hemmingsson e al., 2010; Collis e al., 2006),
ha e e ealed he alue o C. elegans o iden i y genes ela ed o he
cispla in esponse (Table S1). He e, we show, o he i s ime, ha
cispla in in C. elegans p oduces DNA adduc s and a sys emic
esponse d i en by wo conse ed ansc ip ion ac o s. We ha e
unco e ed a spe m-speci ic sensi i i y o cispla in and ha e
demons a ed ha esis ance o he nema ode o cispla in elies on
he p esence o a single selenocys ein o he hio edoxin educ ase
TRXR-1. Thus, his epo is a mo e comp ehensi e s udy o he
global esponse o C. elegans o cispla in ha also es ablishes a
eliable me hodology o u u e s udies on mechanisms o esis ance
o cispla in ha would con inue con ibu ing o he sea ch o new
a ge s and ma ke s o he bene i o cispla in-based he apies.
RESULTS
A eliable assay o s udy he e ec o cispla in in C. elegans
In C. elegans nema odes, cispla in p oduces a wide a ie y o
pheno ypes depending on he concen a ion, leng h o ea men and
de elopmen al s age o he ea ed animals (Tables S1 and S2).
To implemen a eliable me hodology and sys ema ically in es iga e
he esponse o C. elegans o cispla in, we es ablished dose–
esponse pa e ns du ing la al de elopmen , when cell di isions
occu in soma ic and ge m cells. We exposed a synch onized
popula ion o L1 la ae on nema ode g ow h medium (NGM) pla es
o di e en cispla in concen a ions o 96 h. We obse ed e ec s
anging om a de elopmen al delay a 50 µg/ml o a la al a es a
200 µg/ml (Fig. 1A). Based on his assay, we concluded ha body
leng h a 48 h pos -L1, upon cispla in exposu e om 50 o 75 µg/ml,
is a eliable indica o o he e ec o cispla in du ing C. elegans
de elopmen (Fig. 1B). Thus, we es ablished a me hodology o
in es iga e how dis inc ea men s o gene ac i i ies can in luence
he esponse o C. elegans o cispla in.
T ansc ip ional esponse o C. elegans o cispla in
To explo e he global esponse o nema odes o cispla in, we s udied
ansc ip ional signa u es in RNA sequencing (RNA-seq)
expe imen s. We pe o med his new ansc ip ome analysis using
a mixed-s age nema ode popula ion ha was ea ed o 24 h wi h
60 µg/ml o cispla in, because his dosage o cispla in p oduces
some pheno ypes, bu does no comp omise he iabili y o he
animals. To educe he numbe o alse posi i es, we used wo
Fig. 1. Dose– esponse e ec o
cispla in on C. elegans de elopmen
and RNA-seq o animals exposed
o cispla in. (A) E ec o dis inc
concen a ions o cispla in on la al
de elopmen . Synch onized L1 la ae
we e g own on aga pla es and exposed o
di e en doses o cispla in o 96 h a
20°C. Body leng h alues ep esen mean
and SD (n=50) o wo di e en
expe imen s. (B) Body leng h o
nema odes ha we e g own om L1
s age exposed o di e en doses o
cispla in o 48 h a 20°C. Ba s ep esen
mean and SD o h ee independen
eplica es (n=50, N=3). (C) Schema ic
ep esen a ion o ansc ip omic analyses.
Wild- ype C. elegans om mixed s ages
we e cul u ed wi h and wi hou cispla in
(60 µg/ml) o 24 h a 20°C. Then, o al
mRNA o wo biological eplica es was
pu i ied and sequenced. Volcano plo
ep esen s genes signi ican ly up- and
down egula ed (P<0.01) in cispla in-
ea ed e sus un ea ed animals.
(D) Colo code ep esen s he unc ional
ca ego ies o up- o down egula ed genes.
Genes we e clus e ed acco ding o he
gene unc ional classi ica ion ool DAVID
and GO e ms e ie ed om Wo mBase.
2
RESEARCH ARTICLE Disease Models & Mechanisms (2018) 11, dmm033506. doi:10.1242/dmm.033506
Disease Models & Mechanisms
biological eplica es o compa e he ansc ip omes o ea ed and
non- ea ed popula ions (Fig. 1C). We used he Cu links algo i hm
(T apnell e al., 2012) o p ocess he RNA sequencing da a and
s udy di e en ial exp ession o genes. We iden i ied a se o 83
genes up egula ed and 78 genes down egula ed by cispla in in bo h
expe imen s (P≤0.05; Table S3). A mo e es ic ed lis o
candida es, using a cu -o P- alue o ≤0.01, included 28 genes
up egula ed and 29 down egula ed upon cispla in exposu e.
To explo e he unc ions o hese 57 genes, we pe o med a gene
on ology (GO) analysis and iden i ied p edic ed p o ein domains
(COG) (Ta uso e al., 2003; Huang e al., 2009) (Fig. 1D). Genes
encoding CUB-like domains, C- ype lec ins and glu a hione-S-
ans e ases we e ound among he genes up egula ed upon cispla in
exposu e. In C. elegans, he exp ession o such genes is associa ed
wi h de oxi ica ion, edox balance, s ess esponse and inna e
immune sys em, and i is o en egula ed by he ansc ip ion ac o s
DAF-16 and SKN-1 (Singh and Aballay, 2009; Pa k e al., 2009;
Yen e al., 2011; Teppe e al., 2013) (Table S4). We also de ec ed an
o e lap wi h genes induced upon ionizing adia ion (IR) (G eiss
e al., 2008; Schumache e al., 2005a,b) (Table S4). Among hose,
we ound genes in ol ed in he apop o ic signaling cascade,
including egl-1 and ced-13 (G eiss e al., 2008). Howe e , as
desc ibed below, hese wo genes unc ion in a dis inc manne upon
cispla in exposu e.
O he 29 genes down egula ed by cispla in, we ound ha mos
o hose we e spe m-speci ic genes (O iz e al., 2014), wi h he
Majo Spe m P o ein (MSP) domain as he mos equen GO
anno a ion (Table S5). The e o e, he educed b ood size induced by
cispla in migh be p o oked, a leas in pa , by a speci ic e ec o
his agen on spe ma ogenesis and/o on spe m ac i i y.
Cispla in educes he ge m cell pool and a ec s spe m
unc ionali y
Ou ansc ip ome analyses indica ed ha male ge mline genes a e
pa icula ly down egula ed in he p esence o cispla in. To
in es iga e he e ec o cispla in on he ge mline, we exposed L4
animals o cispla in o 24 h, because he swi ch om
spe ma ogenesis o oogenesis occu s a his s age and he e o e
bo h p ocesses can be a ec ed (Ellis and Schedl, 2007). As
expec ed, we obse ed a dose-dependen educ ion o he b ood
size upon cispla in exposu e (Meie e al., 2014) (Fig. 2A). This
educ ion was co ela ed wi h an inc ease in he numbe o
un e ilized eggs laid (Fig. 2A) and a dec ease in he numbe o
cells a he p oli e a i e egion o he ge mline (Fig. 2B). We
obse ed ha cispla in- ea ed ge mlines displayed ewe nuclei in
he mi o ic egion ha appea ed o be bigge (Fig. 2C), which is an
e ec desc ibed in ge mlines exposed o DNA-damaging agen s
ha is a ibu able o cell cycle a es upon ac i a ion o he S-phase
checkpoin (Ga ne e al., 2004).
The inc eased numbe o un e ilized oocy es is a pheno ypic
hallma k o spe m ailu e in C. elegans (Kadandale and Singson,
2004). To in es iga e whe he he un e ilized oocy es obse ed
upon cispla in ea men we e he esul o de ec i e spe m, we
c ossed cispla in- ea ed he maph odi es wi h un ea ed males. We
obse ed ha spe m om un ea ed males escued, a leas in pa ,
he b ood size and ab oga ed he p esence o un e ilized oocy es
(Fig. 2D). These esul s sugges ha he excess o un e ilized
oocy es is a ibu able o he e ec o cispla in in spe ma ogenesis
a he han in oogenesis.
To in es iga e he e ec o cispla in on spe m unc ionali y, we
used he emale/male s ain og-2(oz40), allowing he ea men o
males and emales independen ly be o e he c oss. og-2(oz40)
emales exposed o cispla in and c ossed wi h og-2(oz40) un ea ed
males showed a educed b ood size, as expec ed om he e ec o
cispla in on mi o ic cells, bu we did no de ec an inc eased
p oduc ion o un e ilized oocy es (Fig. 2E). On he con a y, by
c ossing og-2(oz40) males exposed o cispla in wi h un ea ed
og-2(oz40) emales we obse ed a s onge educ ion o he
p ogeny, bu also a highe numbe o un e ilized oocy es. These
esul s con i m ha , a a simila dose, cispla in does no hampe he
capaci y o oocy es o be e ilized bu a ec s he capabili y o spe m
o e ilize.
In summa y, he exposu e o cispla in p oduces smalle ge mlines
as consequence o a educ ion o he p oli e a i e egion and
e iliza ion p oblems caused by he e ec o cispla in in he spe m
(Fig. 2F).
DAF-16 and SKN-1 a e key playe s in he esponse o
cispla in
The abundance o dod (downs eam-o -da -16) genes and o he
s ess esponse genes in he lis o genes up egula ed upon cispla in
exposu e led us o s udy he ole o DAF-16 and SKN-1. These a e
he o hologs o human FOXO3 and NRF2, espec i ely, and a e
equi ed o s ess esis ance in C. elegans (Rod iguez e al., 2013).
S ikingly, we ound ha hal o he up egula ed genes we e
p e iously epo ed as DAF-16 and/o SKN-1 a ge s (Fig. 3A).
The e olu iona ily conse ed insulin/insulin-like g ow h ac o
signaling (IIS) pa hway, h ough i s main ansc ip ion ac o DAF-
16/FOXO, con ols many di e en biological p ocesses and
egula es a wide a ie y o s esses, including s a a ion, oxida i e
s ess (Honda and Honda, 1999), hea y me al oxici y (Ba sy e
e al., 2001) and ul a iole adia ion (Mu akami and Johnson,
1996). DAF-16 is cons i u i ely exp essed and seques e ed in
he cy oplasm in i s phospho yla ed o m. I he inhibi o y
phospho yla ion is comp omised, e.g. by educed signaling o he
DAF-2 ecep o y osine kinase o s ess condi ions, DAF-16 will
ansloca e o he nucleus. Using a DAF-16::GFP epo e s ain, we
obse ed ha DAF-16 nuclea loca ion inc eased upon cispla in
exposu e in a dose-dependen manne (Fig. 3B), con i ming he
implica ion o he IIS pa hway in he esponse o cispla in.
Nex , we in es iga ed he ex en o which he manipula ion o he
IIS ac i i y could modi y he esponse o he o ganism o cispla in.
We obse ed ha da -2(e1370) mu an s, which a e animals lacking
a unc ional DAF-2/IGF-1-like ecep o ha cons i u i ely induce
DAF-16 nuclea localiza ion (Yen e al., 2011), display esis ance o
cispla in du ing la al de elopmen (Fig. 3C). Consis en ly, da -
16(mu86) mu an s we e hype sensi i e o cispla in (Fig. 3C),
highligh ing he ele ance o DAF-16 nuclea ac i i y in he cellula
esponse o cispla in.
Di e en ly om da -2 and da -16,skn-1 is an essen ial gene
hampe ing he use o loss-o - unc ion mu an s. To con i m he
implica ion o SKN-1 in he esponse o cispla in, we used a GFP
epo e o one o i s canonical a ge s, gs -4. SKN-1 egula es he
s ess-induced gs -4 ansc ip ion in he p esence o edox ac i e
compounds, such as pa aqua o hea y me als (Tawe e al., 1998;
Roh e al., 2006). In ou RNA-seq da a, gs -4 is one o he SKN-1-
egula ed genes s ongly induced by cispla in, and we alida ed his
esul using a gs -4 ansc ip ional GFP epo e (Fig. 3D,E).
Mo eo e , using skn-1 RNA in e e ence (RNAi) we con i med ha
he cispla in induc ion o gs -4 exp ession was skn-1 dependen and
da -16 independen (Fig. 3D,E). Thus, by s udying he impac o
cispla in in he global gene exp ession we unco e ed a sys emic
esponse o he o ganism ha is d i en by wo conse ed
ansc ip ion ac o s. The ac ha hese ansc ip ion ac o s a e
3
RESEARCH ARTICLE Disease Models & Mechanisms (2018) 11, dmm033506. doi:10.1242/dmm.033506
Disease Models & Mechanisms
e ec o s o me abolic and en i onmen al signals opens new
a enues o egula e he esponse o cispla in in mul icellula
o ganisms.
The BH3-only p o ein CED-13 p o ec s agains cispla in
We demons a e, o he i s ime, ha cispla in leads o he
o ma ion o DNA adduc s in C. elegans (Fig. 4A) and induces
he exp ession o wo apop osis- ela ed genes, egl-1 and ced-13,
which encode BH3-only p o eins, which a e a subse o he Bcl-2
amiliy ha con ain only a BH3 domain and p omo e apop osis.
egl-1 and ced-13 a e ansc ip ionally induced upon DNA damage
(also upon exposu e o UV o IR; S e giou e al., 2007), and his
induc ion is CEP-1/P53 dependen (G eiss e al., 2008). Y47G7B.2,
ano he cispla in-induced gene in ou RNA-seq, encodes a
nema ode-speci ic gene ha is also up egula ed upon DNA
damage in a cep-1-dependen manne (G eiss e al., 2008). Thus,
he e ec s o cispla in on up egula ion o apop o ic genes could be
a ibu able o cep-1-dependen DNA damage.
egl-1 is equi ed o DNA damage-induced apop osis in bo h
soma ic issues and he ge mline (Ga ne e al., 2000). We
in es iga ed egl-1 induc ion upon cispla in exposu e in he
soma using a GFP epo e s ain (egl-1p::GFP). Du ing la al
de elopmen , only 18 soma ic cells o wild- ype nema odes
unde go apop osis a he ea ly L2 s age (Le e and Henga ne ,
2006). S ikingly, a 24 h cispla in ea men in C. elegans ( om L1
o L2) induced ec opic egl-1p::GFP exp ession ha was e iden in
soma ic cells (Fig. 4B,C). Mo eo e , his cispla in-induced egl-1
ec opic exp ession was, a leas in pa , cep-1 dependen (Fig. 4D).
In he canonical DNA damage-induced apop o ic pa hway, cep-1
is ups eam o he BH3-only p o eins EGL-1 and CED-13.
Howe e , ced-13, and i s downs eam gene ced-3,ha ean
addi ional ole in he in insic apop o ic pa hway ha p omo es
Fig. 2. E ec o cispla in in he ge mline. (A) Cispla in educes b ood size and inc eases he pe cen age o un e ilized oocy es laid. L4 animals we e exposed o
cispla in o 24 h a he indica ed concen a ions (n=12, N=2). (B) Cispla in educes he numbe o ge m cells in he p oli e a i e egion o C. elegans ge mline.
Numbe o cells co esponds o nuclei obse ed, in a single z-s ack, a he p oli e a i e egion (50 μm away om he dis al end o he gonad) (n=15, N=2).
(C) Rep esen a i e DAPI s aining o young adul ge mline exposed o cispla in o 24 h. Righ panels show magni ica ion o he ge mline p oli e a i e egion
(highligh ed a ea). (D) Impac o cispla in on e iliza ion. Cispla in p oduces un e ilized oocy es and causes educed b ood size in sel - e ilized he maph odi e
wo ms (‘Sel ’), bu hise ec is escued, in pa , by c ossing cispla in- ea ed he maph odi es wi h un ea ed males (‘C oss’;n=12, N=2). ***P>0.001, **P>0.01, *P>0.1;
n.s., non-signi ican . (E) Cispla in-induced un e ilized oocy es a e caused by de ec i e spe m. og-2(oz40) he maph odi es do no p oduce spe m, and ma ing is
necessa y o main ain he s ain. Cispla in p oduces un e ilized oocy es only when males a e ea ed (n=12, N=2).
++
P>0.01,
+
P>0.1 compa ed wi h emale ea men
in he same condi ions. (F) Schema ic diag am o illus a e he e ec o cispla in in he ge mline: bigge nuclei a he p oli e a i e zone (ligh blue), de ec i e spe m
( ed do s) and un e ilized oocy es (blue a ow). Ba s show mean and s.e.m., and S uden ’s - es was applied.
4
RESEARCH ARTICLE Disease Models & Mechanisms (2018) 11, dmm033506. doi:10.1242/dmm.033506
Disease Models & Mechanisms
p o ec i e changes a he han killing damaged i epa able cells
(Yee e al., 2014). Acco dingly, we ound ha ced-13 and ced-3
mu an s we e sensi i e o cispla in, whe eas wo di e en cep-1
mu an s we e no esis an o cispla in (Fig. 4E,F).
In summa y, du ing C. elegans la al de elopmen , cispla in
induces he exp ession o egl-1 and ced-13, bu hei in luence is
dis inc . Inhibi ion o he canonical DNA damage-induced apop o ic
pa hway by using cep-1 mu an s does no p oduce animals esis an
o cispla in. On he con a y, ced-13 and ced-3 mu an s a e sensi i e
o cispla in, unde sco ing a p o ec i e ole o he in insic apop o ic
pa hway upon cispla in exposu e in soma ic cells.
TRXR-1 ac i i y con e s sys emic sensi i i y o cispla in
The majo i y o C. elegans genes ela ed o cispla in esponse
published o da e p esen cispla in sensi i i y i inac i a ed by RNAi
o mu a ion (Table S1). The human o hologs o hese genes a e
po en ial a ge s o he apies o e-sensi ize cispla in- esis an
umo s. Gi en he clinical impo ance o iden i ying e ac o y
pa ien s, we wonde ed whe he ou sys em was also aluable o he
s udy o genes whose inac i a ion con e s esis ance o cispla in. In
he clinic, mu a ions o single nucleo ide polymo phisms in hese
genes could unc ion as p edic i e ma ke s o cispla in esponse. In
human cell lines, hio edoxin educ ase 1 (TRXR1, also known as
TXNRD1) selenocys eine amino acid is a di ec a ge o cispla in,
p oducing cy o oxic and highly p o-oxidan TRXR1 o ms called
SecTRAPs, which lead o high edox s ess esul ing in cell dea h
(Anes ål e al., 2008). TRXR1 is one o he ew selenop o eins
[p o eins ha include a selenocys eine (SeCys) amino acid] in
mammals, bu TRXR-1 is he only selenop o ein in C. elegans (Li
e al., 2012) and, in con as o mammals, his p o ein is no essen ial
Fig. 3. Role o DAF-16/FOXO and SKN-
1/N 2 ansc ip ion ac o s in he
esponse o cispla in. (A) Venn
diag ams showing he signi ican o e lap
be ween he genes induced by cispla in
ound in ou ansc ip omic analyses and
genes egula ed by DAF-16 (Teppe e al.,
2013) and SKN-1 (Oli ei a e al., 2009).
P<0.001 by Fishe ’s es . (B) Cispla in
induces DAF-16 nuclea ansloca ion.
Rep esen a i e image o L2 la ae
ca ying a ansla ional GFP epo e o
DAF-16 wi h and wi hou cispla in
(90 µg/ml o 5 h). The g aph ep esen s
he pe cen age o synch onized L2 la ae
wi h DAF-16::GFP p edominan ly nuclea
a e 5 h o exposu e o cispla in a he
indica ed concen a ions. Ba s ep esen
mean and s.e.m. (n=50, N=3). **P<0.01
ela i e o un ea ed wo ms by S uden ’s
- es . (C) IIS pa hway in luences he
esponse o cispla in. Body leng h o
synch onized L1 la ae g own o 4 days in
he absence o p esence o cispla in.
Wo ms we e g own a 15°C o a oid da -
2(e1370) daue pheno ype. The
inac i a ion o he IIS pa hway in da -
2(e1370) mu an s, which keeps DAF-16
cons i u i ely in he nucleus, causes
esis ance o cispla in, whe eas he da -
16(mu86) null mu an inc eases cispla in
sensi i i y. T anslesion syn hesis
polyme ase 1 mu an allele polh-1(i 31)
was used as a posi i e con ol (Roe ink
e al., 2012). Ba s ep esen mean and SD
(n=50). ***P<0.001 ela i e o un ea ed
wo ms by S uden ’s - es . (D) Cispla in-
induced ac i a ion o gs -4 is egula ed by
SKN-1. Rep esen a i e images o
synch onized gs -4p::GFP L4/young adul
animals g own a 20°C on da -16(RNAi)
o skn-1(RNAi) bac e ia om he L1 s age
in he p esence o absence o cispla in.
skn-1(RNAi) inhibi s he cispla in-induced
gs -4 exp ession. Wo ms ed wi h g p
RNAi we e used as a posi i e con ol.
(E) Fluo escence in ensi y o each
condi ion. Ba s ep esen he mean. E o
ba s indica e he s.e.m. (n=30, N=2).
***P<0.001 ela i e o un ea ed animals
by S uden ’s - es .
5
RESEARCH ARTICLE Disease Models & Mechanisms (2018) 11, dmm033506. doi:10.1242/dmm.033506
Disease Models & Mechanisms

o iabili y (S en all e al., 2011). Deple ion o C. elegans x -1
does no p oduce pheno ypes in e ms o mo phology, g ow h,
li espan, b ood size o esponse o oxida i e s ess. I is essen ial
only o la al mol ing when he glu a hione educ ase gene gs -1 is
inac i a ed in pa allel (S en all e al., 2011). All hese ea u es
make C. elegans an excellen mul icellula sys em in which o
s udy speci ically he ole o he SeCys esidue in he esponse
o cispla in.
Fig. 4. Role o apop o ic pa hways in he esponse o C. elegans o cispla in. (A) Sou he n blo showing ha 1,2-GpG-in as and c osslinks a e aised upon
cispla in exposu e o a C. elegans popula ion. The e is a dose-dependen accumula ion o DNA adduc s in he p esence o cispla in. NRK-52E a cells, in which
1,2-GpG-in as and c osslinks a e no p esen (K u
ge e al., 2016), we e incuba ed wi h cispla in as a posi i e con ol. (B) Cispla in induces egl-1 ec opic
exp ession in soma ic issues du ing la al de elopmen . Rep esen a i e images o L2 wo ms ca ying a egl-1p::GFP epo e , un ea ed and ea ed wi h cispla in
(60 µg/ml o 24 h a 20°C). (C) Quan i ica ion o wo ms wi h ec opic egl-1p::GFP luo escence in soma ic cells o synch onized L1 la ae g own a he indica ed
concen a ions o cispla in o 24 h a 20°C. Ba s ep esen mean and s.e.m. o h ee di e en expe imen s (n=50). **P<0.01 by S uden ’s - es . (D) egl-1 ec opic
induc ion in soma ic cells equi es cep-1/p53. Quan i ica ion o cells wi h ec opic egl-1p::GFP luo escence o L1 la ae exposed o 60 µg/ml o cispla in o
24 h a 20°C in wild- ype and cep-1(gk138) mu an s. Ba s ep esen mean and s.e.m. o h ee di e en expe imen s (n=50). ***P<0.01 by S uden ’s - es .
(E,F) Inac i a ion o he cep-1/p53 apop o ic pa hway does no inc ease cispla in esis ance. (E) Body leng h o L1 la ae o wild- ype and dis inc mu an alleles
g own in cispla in (60 µg/ml) o 48 h a 20°C. Ba s ep esen mean and s.d. (n=50). This expe imen was pe o med h ee imes wi h simila esul s. (F) Rela i e
alues o g ow h delay we e ob ained by calcula ing he pe cen age o he di e ence in he body leng h be o e and a e cispla in exposu e (non-pa ame ic
K uskal–Wallis es , ***P<0.001; *P< 0.05; n.s., non-signi ican ).
6
RESEARCH ARTICLE Disease Models & Mechanisms (2018) 11, dmm033506. doi:10.1242/dmm.033506
Disease Models & Mechanisms
We es ed he obus ness o ou model by s udying he ole o
hio edoxin educ ase 1 ( x -1)in heC. elegans esponse o cispla in.
We used he CRISPR/Cas9 sys em o p oduce wo endogenous
TRXR-1 a ian s, x -1(ce 4[U666C])and x -1(ce 5[U666STOP]),
ha change he selenocys eine o cys eine and a STOP codon,
espec i ely (Fig. 5A). In a simila manne o he null mu an x -
1(s 47), hese missense mu a ions showed la al a es , a ibu able o
mol ing de ec s, in combina ion wi h gs -1(RNAi) (Fig. 5B). S ikingly,
bo h he null mu an and he poin mu a ions wi hou he selenocys eine
p oduce esis ance o cispla in (Fig. 5C). Thus, bo h he de elopmen al
unc ion and he capaci y o p omo e cy o oxici y in he p esence o
cispla in ely on he p esence o he selenocys eine esidue.
The e o e, he elec ophilic ac i i y o hyd olyzed cispla in in he
p esence o selenocys eine migh p oduce cy o oxic SecTRAP
o ms ha a e majo d i e s o he ha m ul e ec o cispla in on
mul icellula o ganisms (Fig. 5D).
We also explo ed he ole o x -1 in sensi izing he animal o
cispla in. We ound ha x -1(s 47) con e s esis ance in ge m cells
and in soma ic cells. In e es ingly, by combining x -1(s 47) wi h
da -2 and da -16 mu a ions, he IIS pa hway is epis a ic o he x -1
ac i i y on cispla in esis ance (Fig. S1).
DISCUSSION
Despi e h ee decades o clinical use and in ense esea ch, g ea e
knowledge is necessa y o unde s and, and ul ima ely con ol, he
molecula e en s d i ing endogenous and acqui ed esis ance o
pla inum-based chemo he apy (Dil uba and Kalayda, 2016). In his
con ex , model o ganisms a e pla o ms wi h g owing in e es in
he s udy o he molecula , cellula and sys emic esponses o
chemo he apeu ic agen s, bu also o sc een o new ea men s
(Nijman, 2015). He e, we ein o ce he use o C. elegans o s udy he
complex esponse o mul icellula o ganisms o cispla in. The
unc ion o C. elegans genes in he esponse o cispla in has been
shown in di e en biological con ex s as adul su i al o ge mline
apop osis (Table S1). A e es ing some o hese con ex s, we
selec ed he body leng h o de elopmen al la ae as a eliable and
Fig. 5. x -1 null and missense mu an s a e esis an o cispla in. (A) Rep esen a ion o he x -1 gene. Blue boxes ep esen exons, and lines
ep esen in ons. The uppe line deno es he 1663 bp egion dele ed in he s 47 allele. Selenocys eine codon TGA is he hi d las esidue and is ep esen ed as
Sec. The wild- ype sequence o he las ou codons and hei co esponding amino acids a e boxed below. ce 4[U666C] and ce 5[U666STOP] Sec-de icien
x -1 mu an alleles, edi ed by CRISPR/Cas9, ca y a single subs i u ion in Sec codon (C ins ead o A o A ins ead o G) ha changes he selenocys eine o
cys eine o a p ema u e STOP codon, espec i ely. (B) Sec-de icien ce 4[U666C] and ce 5[U666STOP] alleles, in a simila manne o he x -1 null allele, cause
a mol ing-associa ed g ow h a es when ed wi h gs -1(RNAi). G aph shows he quan i ica ion o la al a es o L1 la ae ed wi h gs -1(RNAi) o con ol bac e ia
(emp y ec o ). Ba s ep esen mean and s.d. (n=50, N=2). (C) x -1(s 47) null mu an and ce 4[U666C] and ce 5[U666STOP] poin mu an s ains show
inc eased esis ance o cispla in. Body leng h quan i ica ion o synch onized L1 la ae g own on aga pla es con aining 0 and 60 µg/ml o cispla in o 48 h a 20°C.
Ba s ep esen mean and s.d. (n=50). This expe imen was pe o med in iplica e wi h simila esul s. ***P<0.001 ela i e o wild- ype wo ms in he same
condi ions by S uden ’s - es . (D) Schema ic diag am o he cy o oxic e ec p oduced by he elec ophilic ac i i y o cispla in when eac ing wi h a selonocys ein
p esen in hio edoxin educ ase 1.
7
RESEARCH ARTICLE Disease Models & Mechanisms (2018) 11, dmm033506. doi:10.1242/dmm.033506
Disease Models & Mechanisms
scalable sys em o e alua e he esponse o he animal o cispla in.
Nema odes a e easy o synch onize a he L1 s age, and he e o e we
can s udy homogeneous popula ions du ing la al de elopmen ,
when soma ic and ge m cells a e in ac i e p oli e a ion and
apop o ic pa hways unc ional.
The C. elegans ge mline is di e se in cell ypes, because i
con ains mi o ic cells, meio ic cells, ma u e oocy es and spe m. We
obse ed ha he e ec o cispla in on e ili y and cell cycle a es
in he mi o ic ge mline is simila o ha p oduced by o he DNA-
damaging insul s, such as ionizing o ul a iole C adia ions
(Ga ne e al., 2004), sugges ing a di ec ac ion o cispla in on DNA
ha is suppo ed by ou sou hwes e n blo s o DNA adduc s (1,2-
GpG-in as and c osslinks). This cispla in-induced DNA damage
esponse (DDR) in he C. elegans ge mline has al eady been
documen ed ( an Haa en e al., 2006; Meie e al., 2014; Honnen,
2017). In addi ion, howe e , we ound ha de ec i e spe m is a
majo cause o he educed C. elegans e ili y obse ed upon
cispla in exposu e a L4. A his s age, we hi oogenesis only
pa ially, bu ou expe imen s wi h og-2 mu an s sugges ha spe m
and oocy es a e di e en in e ms o esis ance o cispla in.
In e es ingly, cispla in is pa icula ly e icien o es icula umo s
and causes a d as ic e ec on spe ma ogenesis and spe m in ea ed
pa ien s, bu his ha m ul e ec seems o a ec p ima ily he
ch oma in and is e e sible (Bujan e al., 2013). In emales wi h
o a ian cance , cispla in also a ec s game ogenesis, p oducing a
educ ion o he o a ian ese e (Chang e al., 2015). De ailed
expe imen s need o be pe o med o gain a be e unde s anding o
he s ep a which game ogenesis is hampe ed in he p esence o
cispla in. In his sense, he he maph odi e condi ion o C. elegans is
a clea ad an age o s udy he e ec o any gi en cispla in dose on
oogenesis and spe ma ogenesis in he same o ganism.
Ou RNA-seq analyses e ealed a ansc ip omic signa u e in
he p esence o cispla in. The cispla in- esponsi e genes iden i ied
could be in ol ed in cell au onomous mechanisms (cells ha e an
indi idual esponse o cispla in up ake) o in non-cell au onomous
mechanisms ( he e ec in ce ain cells in luences dis an cells).
Gi en ha DNA is damaged by cispla in, a cell-au onomous
esponse occu s as a checkpoin mechanism o a o DNA epai
(Ga ne e al., 2004). Ne e heless, he as majo i y o genes
induced by cispla in in ou expe imen s a e ela ed o gene al s ess
esponses and he inna e immune sys em, which sugges s a
coo dina ed sys emic esponse. Acco ding o he de egula ed
genes, his esponse has DAF-16 and SKN-1 as majo d i e s and
has simila i ies o ha ob ained om nema odes exposed o IR o
UV-C (Boyd e al., 2010; G eiss e al., 2008). DAF-16 ac i a ion
posi i ely egula es a wide spec um o p ocesses, such as s ess
esis ance, inna e immuni y and me abolic adap a ion (Singh and
Aballay, 2009; Mu phy and Hu, 2013), whe eas he NRF2 C.
elegans o holog SKN-1 is an impo an ac o in de oxi ica ion
and esponse o oxida i e s ess, and i s down egula ion has been
associa ed wi h hype sensi i i y o di e en s esso agen s
(Blackwell e al., 2015).
In e es ingly, immune and s ess eac ions upon DNA damage a e
common in mammals (E molae a and Schumache , 2013), and
simila o wha we obse ed in C. elegans, cispla in induces he
nuclea ansloca ion o he DAF-16 homolog FOXO3 (Fe nandez
de Ma os e al., 2008). Human FOXO p o eins a e c ucial egula o s
o a mul i ude o cellula unc ions (Yang and Hung, 2009), bu ou
esul s encou age u he explo a ion o he manipula ion o he IIS
pa hway o con ol he cellula esponse o cispla in.
The SKN-1 human o holog NRF2 egula es he exp ession o
s ess- esponsi e genes, such as SOD and ca alases, o phase II
de oxi ica ion enzymes, such as glu a hione ans e ases (Kaspa
e al., 2009). NRF2 o e exp ession o hype ac i a ion p o okes a
di ec e ec in acquisi ion o esis ance o a wide spec um o
an icance d ugs in many cance ypes (Gañán-Gómez e al., 2013;
Kaspa e al., 2009). Acco dingly, inc eased nuclea NRF2
exp ession has been shown in cispla in- esis an human bladde
cance samples (Hayden e al., 2014). On he con a y, inhibi ion o
NRF2 sensi izes cispla in- esis an A549 cells (Hou e al., 2015).
These obse a ions a e conco dan wi h ou indings in C. elegans,
sugges ing ha di ec o indi ec a ge ing o NRF2 should be
explo ed o cispla in-combined he apeu ic in e en ions.
Ou ansc ip omic analyses unco e ed he up egula ion o egl-1
and ced-13, which a e ela ed o apop osis. Using a egl-1p::GFP
epo e , we ound ec opic exp ession in soma ic cells. The apop o ic
pa hway in pos emb yonic soma ic cells is no well desc ibed and
migh be di e en in each soma ic cell ype. In he canonical iew o
he DNA damage-induced apop o ic pa hway, exp ession o he
e ec o EGL-1 ma ks cells des ined o die (Nehme and Con ad ,
2008), and cep-1/p53 is ups eam (Schumache e al., 2005a).
Howe e , egl-1p::GFP is s ill o e exp essed in cep-1/p53 mu an s
exposed o cispla in, indica ing ha inhibi ion o he DNA damage-
induced apop o ic pa hway does no comple ely p o ec he animal
om cispla in oxici y. Likewise, blockade o apop osis in adul
wo ms h ough cep-1/p53 inhibi ion does no ha e any e ec on
cispla in sensi i i y (Hemmingsson e al., 2010). Thus, inhibi ion o
he DNA damage-induced apop o ic pa hway is no an e icien
s a egy o animals o hampe he global e ec o cispla in.
None heless, exp ession o cep-1/p53 seems o be impo an o he
ull esponse o cispla in, and p53 is equi ed o he cy o oxic e ec
o cispla in in human glioblas oma cells (Pa k e al., 2006).
Su p isingly, we ound ha ced-13 up egula ion migh ha e a
p o ec i e ole, because ced-13 mu an s a e sensi i e o cispla in.
Mu an s o ced-3, a gene ha is gene ically downs eam, a e also
sensi i e o cispla in. This esul i s wi h he ole o ced-13 in he
mi ochond ial in insic apop o ic pa hway ha ex ends C. elegans
longe i y (Yee e al., 2014). I is possible ha pos mi o ic cells,
which a e i eplaceable, ac i a e ced-13 ac i i y o p o ec hemsel es
om cispla in. The ole o ced-13 migh be dependen on he insul
le els o a y in dis inc cell ypes, because o e exp ession o ced-13
in he soma induces cell dea h o soma ic cells ha no mally su i e
(Schumache e al., 2005a). In conco dance wi h a p o ec i e ole o
ced-13 and ced-3, he ac i i y o hese genes appea s o p o ec
dopamine gic neu ons om he oxici y o an oxida i e s ess-
inducing d ug (O enbu ge e al., 2018).
Thio edoxin sys em p o eins a e key playe s in many impo an
cellula p ocesses, including he main enance o edox homeos asis
(A né , 2009; Lu and Holmg en, 2014). Rega ding he in luence o
hio edoxins in he cellula esponse o cispla in, in mammalian
cells i has been shown ha a delica e balance exis s be ween he
cy o oxic e ec o he di ec in e ac ion wi h cispla in and he
p o ec i e e ec , main aining he edox equilib ium (Anes ål e al.,
2008; Cebula e al., 2015). S udies in cell lines sugges ha
cispla in cy o oxici y is p omo ed by a di ec in e ac ion be ween
cispla in and selenocys eine amino acids, leading o he consequen
o ma ion o SecTRAPs (Anes ål e al., 2008). We con i med he
cispla in-induced cy o oxici y o TRXR-1 and, gene a ing wo
dis inc missense mu a ions by CRISPR/Cas9, we demons a ed
ha his cy o oxici y elies on he p esence o a single
selenocys ein (Sec) a he C- e minal o he p o ein. In e es ingly,
he p esence o Cys ins ead o Sec in TRXR1 can be modula ed by
he p esence o he mic onu ien selenium in he die o a s
(Lu e al., 2009).
8
RESEARCH ARTICLE Disease Models & Mechanisms (2018) 11, dmm033506. doi:10.1242/dmm.033506
Disease Models & Mechanisms
The mul i ac o ial na u e o cispla in esis ance hampe s he
inding o a unique solu ion o o e come he esis ance o umo s o
cispla in. Howe e , he e a e many pa allels be ween he esponse
o C. elegans and mammals o a cispla in ea men ha would
acili a e he s udy in nema odes o pa icula gene ic, me abolic and
en i onmen al ac o s in luencing he esis ance o cispla in. This
in o ma ion would be o g ea help o iden i y p edic i e bioma ke s
and in es iga e new d ugs o ha e mo e e ec i e and pe sonalized
cispla in-based he apies.
MATERIALS AND METHODS
Nema ode s ains and gene al me hods
Caeno habdi is elegans s ains we e cul u ed and main ained using s anda d
p ocedu es (Po a-de-la-Ri a e al., 2012; S ie nagle, 2006). The N2
(B is ol) s ain was used as wild- ype in all expe imen s, and he ollowing
alleles and ansgenic s ains we e used in his s udy: BS553, og-2(oz40) V;
XF132, polh-1(i 31) III; CB1370, da -2(e1370) III; TJ1, cep-1(gk138) I;
CE1255, cep-1(ep347) I; FX536, ced-13( m536) X; MD792, ced-13(s 32)
X; VB1414, x -1(s 47) IV; CER170, x -1(ce 4[U666C])IV; CER171,
x -1(ce 5[U666s op])IV; CF1038, da -16(mu86) I; TJ356, zIs356
[da -16p::da -16a/b::GFP + ol-6(su1006)] IV; WS1973, opIs56 [egl-
1p::2xNLS::GFP]; CER192, cep-1(gk138) I, opIs56(egl-1p::GFP); and
CL2166, d Is19 [pAF15(gs -4p::GFP::NLS)] III.
CRISPR/Cas9
To gene a e he x -1(ce 4[U666C])and x -1(ce 5[U666S op])poin
mu a ion alleles, we a ge ed a si e nea he selenocys eine codon wi h
CRISPR/Cas9. To make he sgRNA exp ession plasmid, we cloned he
annealed oligonucleo ides in o BsaI-diges ed U6::sgRNA pMB70
(Waaije s e al., 2013). Repai empla es con aining desi ed modi ica ions
we e designed by Gibson Assembly Cloning Ki (New England BioLabs)
and cloned in o he pBSK plasmid (Addgene). Oligonucleo ide sequences
used o gene a e he 5′and 3′1.5 kb o e lapping agmen s a e a ailable on
eques . Bo h sgRNA and epai empla e we e e i ied by sequencing using
T4 and M13 p ime s, espec i ely. Young adul wild- ype animals we e
injec ed wi h 30 ng/μl o sgRNA, 100 ng/μl o epai empla e, 30 ng/μlo
Pe -3::Cas9 ec o (F iedland e al., 2013) and 2.5 ng/μlo Pmyo-2::
dToma o. Single luo escen p ogeny we e isola ed and sc eened o he
p esence o he mu a ion by PCR. We inally es ablished and alida ed
homozygous mu an lines by PCR and sequencing.
RNA-sequencing analyses
A mixed popula ion o wo ms ep esen ing all s ages and g own in con ol
condi ions was exposed o 60 µg/ml o cispla in. A e 24 h a 20°C,
cispla in- ea ed wo ms and un ea ed con ol animals we e washed wi h M9
bu e o emo e bac e ia, and o al RNA was ex ac ed using he TRIzol
me hod. To al mRNA was subsequen ly en iched using he mi Vana
miRNA isola ion ki (Ambion) ollowed by poly-A cap u e. Lib a y
cons uc ion and Illumina’s HiSeq 2000 echnology sequencing was
pe o med ollowing he manu ac u e ’s ins uc ions. App oxima ely 12
million eads (100 bp leng h) o each sample we e p ocessed and aligned
using TopHa so wa e o he C. elegans e e ence genome, e sion
WBcel235.74, o p oduce BAM iles [Gene Exp ession Omnibus (GEO)
da abase e e ence GSE111654]. These BAM iles we e analyzed wi h he
SeqSol e NGS so wa e (In eg omics, S.L.), using a alse disco e y a e o
0.05 and il e ing eads displaying mul iple mapping si es. SeqSol e uses
Cu links and Cu di (T apnell e al., 2012) p og ams o pe o m
di e en ial gene exp ession analyses be ween samples (P<0.005).
Exp ession alues we e no malized in FPKM ( agmen s pe kilobase o
exon pe million agmen s mapped). Da ase s o up- and down egula ed
genes we e gene a ed, compa ing he di e en ial gene exp ession analyses
o wo independen eplica es (P<0.01 and P<0.05).
Cispla in assay du ing la al de elopmen
A synch onized popula ion o L1-a es ed la ae was cul u ed on NGM
pla es con aining esh OP50 and 0-200 µg/ml o cispla in (Sigma). The
body leng h o ≥50 wo ms o each condi ion was measu ed a 48, 72 and
96 h a 20°C a he s e eomic oscope using NIS-Elemen s 3.2 imaging
sys em. The subsequen analyses we e pe o med wi h 60 µg/ml o cispla in
in he same condi ions excep o assays con aining da -2(e1370) s ain,
which we e pe o med a 15°C, measu ing he body leng h a e 4 days o
incuba ion o a oid empe a u e- ela ed de elopmen al delay. Each assay
was done in duplica e, and a leas wo biological eplica es we e pe o med.
Nonpa ame ic S uden ’s - es (G aphPad P ism 5) was used o de e mine
he signi icance o di e ences in he mean.
Analysis o he e ec o cispla in in he ge mline
To analyze he e ec o cispla in on he ge mline, a synch onized popula ion
o L4-s age animals g own in s anda d condi ions (39 h a 20°C) was
ans e ed on o NGM pla es con aining 60 µg/ml cispla in. A e 24 h o
incuba ion a 20°C, wo ms we e washed in PBS and ge mlines dissec ed in
wo ms anes he ized wi h 3 mM o le amisol in PBS, ixed wi h 4%
pa a o maldehyde and s ained wi h DAPI (0.6 µg/ml). These s ained gonads
we e pho og aphed using a Nikon ECLIPSE TI-s in e ed mic oscope. Fo
ge m cell quan i ica ion in he p oli e a i e egion, he o al numbe o cells
in a single z-s ack wi hin 50 µm o he dis al end o he gonad was coun ed.
A leas 15 ge mlines we e coun ed o each expe imen .
B ood size and un e ilized oocy es
To pe o m he sel - e iliza ion assays, a synch onized popula ion o L3-s age
wo ms was exposed o NGM pla es, wi h addi ion o esh OP50 and 0, 60 o
100 µg/ml o cispla in o 24 h. A o al o 12 wo ms om each condi ion we e
selec ed on o esh OP50 pla es, coun ing he p ogeny and he numbe o
oocy es laid a e 3 days. A simila p o ocol was pe o med o c ossing
assays, whe e we used ei he a male-en iched popula ion in he case o N2, o
he male– emale popula ion o he og-2(oz40) allele. A e 24 h o exposu e
o cispla in, a o al o 12 gene ic c osses we e pe o med o each condi ion,
placing one he maph odi e, o emale in he case o og-2(oz40), and ou
males on esh OP50 pla es, le ing hem ma e and lay p ogeny o 3 days. This
expe imen was pe o med in duplica e. A nonpa ame ic S uden ’s - es was
used o de e mine he signi icance o di e ences in he mean.
In i o in acellula localiza ion o DAF-16
To de e mine he subcellula localiza ion o DAF-16, a synch onized L2-
s age popula ion o wo ms ca ying he DAF-16::GFP ansgene (TJ356)
was ans e ed o M9 bu e con aining 0, 90 o 180 µg/ml o cispla in o
5 h a 20°C. Then, he wo ms we e washed in M9 and moun ed on a
mic oscope slide con aining a 2% aga pad, using a d op o 3 mM
le amisole o anes he ize hem. We quan i ied he DAF-16 subcellula
localiza ion by conside ing as ‘nuclea ’wo ms showing a mainly nuclea
GFP accumula ion along he whole body, as shown in Fig. 3B. A o al o 50
wo ms we e obse ed in each one o h ee independen eplica es.
egl-p::GFP exp ession assays
To de e mine ec opic egl-1 exp ession, a synch onized L1-s age popula ion
o egl-1p::GFP (WS1973) ansgenic nema odes was g own on NGM pla es
con aining esh OP50 and 60 μg/ml cispla in pla es o 24 h a 20°C. Fo in
i o obse a ion, wo ms we e eco e ed wi h M9 bu e , washed and
moun ed on a mic oscope slide con aining a 2% aga pad, using a d op o
3 mM le amisole o anes he ize hem. We used a Nikon ECLIPSE TI-s
in e ed mic oscope o quan i y he numbe o cells showing an ec opic GFP
signal. These expe imen s we e pe o med h ee independen imes.
RNAi and in i o gs -4 exp ession assay
da -16 and skn-1 RNAi clones used in his s udy we e ob ained om he
ORFeome lib a y (Rual e al., 2004). RNAi by eeding was pe o med in
s anda d condi ions, using NGM pla es supplemen ed wi h 50 μg/μl
ampicillin, 12.5 μg/μl e acycline and 3 mM IPTG. To analyze gs -4
induc ion, a synch onized L1-s age popula ion o gs -4p::GFP epo e
s ain was g own on pla es con aining he co esponding RNAi clone o
24 h a 20°C. Then, wo ms we e ans e ed o new RNAi pla es including 0
o 60 μg/ml cispla in o 24 h. Then, wo ms we e eco e ed wi h M9 bu e ,
washed and moun ed on a mic oscope slide con aining a 2% aga pad, using
a d op o 3 mM le amisole o anes he ize hem. A Nikon ECLIPSE TI-s
in e ed mic oscope was used o in i o obse a ion, and image analysis
9
RESEARCH ARTICLE Disease Models & Mechanisms (2018) 11, dmm033506. doi:10.1242/dmm.033506
Disease Models & Mechanisms